Clinical Trials Directory

Trials / Suspended

SuspendedNCT04086589

Restoring Molecular Circadian Rhythm

Exploratory Pilot Study to Discover Genes That Restore the Molecular Circadian Rhythm

Status
Suspended
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Accepted

Summary

The goal is to address the mechanisms that account for alteration of circadian rhythms with age. As the blood of aged individuals can produce this alteration, the investigators propose to use such blood samples to "age" circadian rhythms in cultured cells. The investigators will verify aged blood-dependent alteration of rhythms and then conduct molecular screens to reverse this decline. If the investigators identify specific genes that can restore molecular circadian rhythm in vitro, the investigators will explore these in animal models (Drosophila, mouse).

Conditions

Interventions

TypeNameDescription
OTHERObservational study without interventionObservational study without intervention

Timeline

Start date
2019-08-19
Primary completion
2028-01-01
Completion
2028-11-01
First posted
2019-09-11
Last updated
2026-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04086589. Inclusion in this directory is not an endorsement.

Restoring Molecular Circadian Rhythm (NCT04086589) · Clinical Trials Directory